Skip to content
  • Sunday, 26 July 2026
  • 4:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Tubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s Diseases
Neuroscience & Brain Research

Tubulin Identified as a Critical Molecular Safeguard Against Neurodegenerative Protein Aggregation in Alzheimer’s and Parkinson’s Diseases

Rifan Muazin Jul 7, 2026 0

Scientists at the Baylor College of Medicine have announced a landmark discovery in the field of neurobiology, identifying a novel…

Read More
Neuroscience & Brain Research

Tubulin Acts as a Molecular Chaperone to Prevent Toxic Protein Aggregation in Alzheimer’s and Parkinson’s Disease Research

Rifan Muazin Jun 21, 2026 0

Scientists at the Baylor College of Medicine have announced a significant breakthrough in the understanding of neurodegenerative pathologies, identifying a…

Read More
Data Science & Bioinformatics

Pandas GroupBy: Revolutionizing Data Analysis with Powerful Aggregation Techniques

Evan Lee Salim May 27, 2026 0

The realm of modern data analysis is characterized by an ever-increasing volume and complexity of data, demanding robust and efficient…

Read More
Researchers Create First Fully Human 3D Bone Marrow Model to Advance Cancer Treatment and Reduce Animal TestingJapanese Researchers Identify Key Protein Interaction Essential for Sperm Development and Male FertilityTWiV 1292: Clinical update with Dr. Daniel GriffinUC San Francisco Researchers Identify FTL1 Protein as Key Driver of Hippocampal Aging and Memory Loss in New Study
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ